The Interventional Oncology Center

Filter Your Results

 

News

 

BTG Launches the ICEfx Cryoablation System

September 20, 2018 -- BTG plc announced the global launch of the ICEfx cryoablation system, which is an evolution of the company's Visual ICE system. The company is introd…

Guerbet’s Lipiodol Ultra Fluid Approved for New Indication in cTACE

September 18, 2018 -- Guerbet LLC announced that it has been granted approval for a new indication for the company's Lipiodol Ultra Fluid in Belgium, Ireland, Portugal, Ho…

AngioDynamics to Acquire RadiaDyne

September 13, 2018 -- AngioDynamics, Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient…

Embolx's Next-Generation Sniper Balloon Occlusion Microcatheters Approved in Europe

September 5, 2018 -- Embolx, Inc., which develops microcatheters for arterial embolization procedures, announced CE Mark certifications for its next-generation Sniper balloon …

Portal Vein Tumor Thrombus in the Presence of Locally Advanced Hepatocellular Carcinoma

Moderator: Sarah B. White, MD, MS, FSIR
Panel: Ricardo Garcia-Monaco, MD, PhD, FSIR; Boris Guiu, MD, PhD; and Yasuaki Arai, MD, FSIR, FCIRSE

August 2018—CASE PRESENTATION A 68-year-old man presents with alcohol cirrhosis (Child-Pugh score, A5; ECOG [Eastern Cooperative Oncology Group] performance status, 0 -- 1). His total …

AngioDynamics Acquires Surgical Specialties' BioSentry System

August 15, 2018 -- AngioDynamics, Inc. announced the acquisition of the BioSentry tract sealant system technology from Surgical Specialties, LLC, a medical device company head…

FDA Grants Breakthrough Therapy Designation for Genentech’s Tecentriq in Combination With Avastin as First-Line Treatment for Advanced or Metastatic HCC

July 18, 2018 -- Genentech, a member of the Roche Group, announced that the FDA has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with A…

Five-Year Results Published for SonaCare's Sonablate HIFU System to Treat Prostate Cancer

July 11, 2018 -- SonaCare Medical, a developer of high-intensity -- focused ultrasound (HIFU) technologies, announced 5-year outcomes from a multicenter study of focal therapy…

 

advertisement

2017 Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.